Dlh / vlastný kapitál spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky Dlh / vlastný kapitál spoločnosti NeuroVive Pharmaceutical AB je 0.42
Aká je definícia metriky Dlh / vlastný kapitál?
Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dlh / vlastný kapitál spoločností v sektore Miscellaneous sektor na LSE v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti NeuroVive Pharmaceutical AB
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Core Lithium Ltd je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti China Health je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Vanguard Specialized Funds - Vanguard Real Estate ETF je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Jagran Prakashan je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Smc Electric je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Indraprastha Medical je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti NeuroVive Pharmaceutical AB je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti PetroTal je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti West Pharmaceutical Services je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Cybele Industries Ltd je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Tandy Leather Factory je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Nephros Inc je 0.42
- Hodnota metriky Dlh / vlastný kapitál spoločnosti SiteMinder je 0.42